• Medical - Distribution
  • Healthcare
Henry Schein, Inc. logo
Henry Schein, Inc.
HSIC · US · NASDAQ
63.92
USD
-5.64
(8.82%)
Company Overview

135 DURYEA RD,MELVILLE NY 11747,6318435500

CEO

Mr. Stanley M. Bergman

Employess

25000

Sector

Healthcare

Industry

Medical - Distribution

Website

https://www.henryschein.com

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Next Earnings Date

Nov. 11, 2024

Ex Dividends date

--

Dividend Date

--

YTD Performance

-15.40%

Fiscal Year End

12-25

IPO Date

1995-11-03

Growth Rates
(avg. rate of change) 10 years 5 years 3 years 1 year
Sales/Revenue 2.58% -1.34% 6.83% -2.44%
EPS 2.39% -1.96% 4.09% -19.49%
Equity 2.76% 4.30% 2.97% 6.07%
Cash -0.98% 16.35% -25.95% 46.15%
Return On Capital (ROIC) 12.28% 11.68% 11.56% 9.14%
Debt
year (millions) 2023 2022 2021 2020 2019
Short Term Debt 494 182 138 248 199
Long Term Debt 1,930 1,320 1,080 754 799
LT Finance Leases 314 348 344 303 242
Shares Outstanding 131 136 140 143 148
Market Cap 9,890 10,900 10,500 9,380 9,840
Price
Business Segments (Beta)
Geographical Segments (Beta)
News
Henry Schein, Inc. (HSIC) Q2 2024 Earnings Call Transcript
1 month

Henry Schein, Inc. (NASDAQ:HSIC ) Q2 2024 Earnings Conference Call August 6, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Chairman & CEO Ronald South - SVP and CFO Conference Call Participants Jon Block - Stifel Jason Bednar - Piper Sandler Elizabeth Anderson - Evercore ISI John Stansel - JPMorgan Dane Reinhardt - Baird Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.

seekingalpha.com
Compared to Estimates, Henry Schein (HSIC) Q2 Earnings: A Look at Key Metrics
1 month

While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com
Henry Schein (HSIC) Q2 Earnings Surpass, 2024 Guidance Slashed
1 month

Henry Schein's (HSIC) second-quarter results reflect an improvement in sales trends in distribution businesses.

zacks.com
Henry Schein (HSIC) Q2 Earnings Beat Estimates
1 month

Henry Schein (HSIC) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.31 per share a year ago.

zacks.com
Henry Schein cuts annual profit forecast as cyberattack impact lingers
1 month

Henry Schein lowered its annual profit forecast on Tuesday as the dental and medical equipment distributor warned of a slower recovery from a cyberattack that was disclosed by the company in October last year.

reuters.com
The Zacks Analyst Blog Baxter International, Henry Schein and IDEXX Laboratories
1 month

Baxter International, Henry Schein and IDEXX Laboratories are included in this Analyst Blog.

zacks.com
What's in Store for These 3 MedTech Stocks in Q2 Earnings?
1 month

MedTech companies' quarterly results are likely to be strong on a sequential basis. Let's see how BAX, HSIC and IDXX are placed ahead of their earnings releases.

zacks.com
Countdown to Henry Schein (HSIC) Q2 Earnings: Wall Street Forecasts for Key Metrics
1 month

Evaluate the expected performance of Henry Schein (HSIC) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

zacks.com
Henry Schein Details Progress in 2023 CARES Report on Sustainability and Corporate Citizenship
2 months

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today released its 2023 CARES Report on Sustainability and Corporate Citizenship. Henry Schein Cares, our global corporate citizenship program, aims to drive positive change through its five pillars: Catalyzing health care access; Advancing policies, solutions and innovation; Relationship-building for change; Empowering Team.

businesswire.com
Earnings Preview: Henry Schein (HSIC) Q2 Earnings Expected to Decline
2 months

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock
2 months

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com
How to Play Henry Schein (HSIC) Ahead of Q2 Earnings?
2 months

Henry Schein (HSIC) is expected to deliver impressive sales in both its businesses in the second quarter of 2024, along with a steady pace of recovery from the cyber incident.

zacks.com